ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases

American Society of Hematology. (2023).
ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases.

American Society of Hematology.
"ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases
(label-accessed October 11, 2024).

"American Society of Hematology."
ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases, 11 Oct. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero